# A Study to Investigate the Procoagulant Effect of Tenecteplase (TNK-tPA), Alteplase (Rt-PA) and Streptokinase (SK) Administered to Patients With Acute Myocardial Infarction (AMI)

> **NCT02182011** · PHASE3 · COMPLETED · sponsor: **Boehringer Ingelheim** · enrollment: 49 (actual)

## Conditions studied

- Myocardial Infarction

## Interventions

- **DRUG:** Tenecteplase
- **DRUG:** Alteplase
- **DRUG:** Streptokinase

## Key facts

- **NCT ID:** NCT02182011
- **Lead sponsor:** Boehringer Ingelheim
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2000-05
- **Primary completion:** 2001-06
- **Final completion:** —
- **Target enrollment:** 49 (ACTUAL)
- **Last updated:** 2014-07-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02182011

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02182011, "A Study to Investigate the Procoagulant Effect of Tenecteplase (TNK-tPA), Alteplase (Rt-PA) and Streptokinase (SK) Administered to Patients With Acute Myocardial Infarction (AMI)". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT02182011. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*